ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis
Abstract Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer with an abysmal prognosis rate over the last few decades. Early diagnosis and prevention could effectively combat this malignancy. Therefore, it is crucial to discover potential biomarkers to identify asymp...
Guardado en:
Autores principales: | Shajedul Islam, Takao Kitagawa, Byron Baron, Yoshihiro Abiko, Itsuo Chiba, Yasuhiro Kuramitsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48f247515c644dd69f27e77125dd8f69 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai,Yi, et al.
Publicado: (2018) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Eric M. Anderson, et al.
Publicado: (2021) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Alexander G. Raufi, et al.
Publicado: (2021) -
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: Iranzu González-Borja, et al.
Publicado: (2021) -
Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
por: Ole Helm, et al.
Publicado: (2014)